Document Detail


TGF-alpha immunoreactivity in laryngeal carcinoma: lack of prognostic value and correlation to EGF-receptor expression.
MedLine Citation:
PMID:  8678876     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Transforming growth factor alpha (TGF-alpha) is a polypeptide that is structurally similar to epidermal growth factor (EGF) that binds to the epidermal growth factor receptor (EGFR) and has been implicated in the development of several types of human tumours. METHODS: The expression of TGF-alpha is examined in laryngeal squamous cell carcinoma (SCC) (n = 24) and non-neoplastic polyps (n = 7) using streptavidin-biotin immunohistochemistry and a monoclonal antibody to the TGF-alpha protein. These cases had been previously characterized for EGFR immunoreactivity. The carcinomas were classified as well differentiated (n = 2), moderately differentiated (n = 16) and poorly differentiated (n = 6). Tissues from metastatic tumour deposits in lymph nodes (n = 5) were also studied. RESULTS: TGF-alpha overexpression was defined as intense immunoreactivity in more than two-thirds of tumour cells immunostained for TGF-alpha and was present in the majority of the SCC cases (n = 15; 63%) and metastatic tumour deposits (n = 4; 80%). In contrast, although some of the vocal cord polyps showed weak (n = 2) to moderate (n = 5) immunostaining, none had evidence of strong TGF-alpha immunoreactivity. The differences in TGF-alpha immunoreactivity were significant between primary laryngeal SCC and vocal cord polyps (P = 0.013; chi 2 test with continuity correction), and between metastatic laryngeal SCC and vocal cord polyps (P = 0.023; chi 2 test with continuity correction). There was no significant difference in TGF-alpha expression between the different grades of carcinomas (P = 0.92, chi 2 test) or between non-metastatic and metastatic carcinomas (P = 0.82; chi 2 test with continuity correction). No significant correlation was found between TGF-alpha expression and patient survival or tumour recurrence (r = 0.077, r2 = 0.006, P = 0.75; simple regression analysis), or between TGF-alpha expression and EGFR immunoreactivity (r = 0.325, r2 = 0.106, P = 0.0851). CONCLUSIONS: In conclusion, increased TGF-alpha immunoreactivity is present in most cases of laryngeal SCC with no specific relationship to tumour grade, suggesting that it may be important in the development of laryngeal carcinomas but not in its progression. No significant correlation was found between TGF-alpha and EGFR expression in laryngeal tumours and TGF-alpha immunoreactivity is of no prognostic value.
Authors:
C S Lee; A Redshaw; G Boag
Related Documents :
12873036 - Effects of nonsteroidal anti-inflammatory drugs on transforming growth factor-beta expr...
3308436 - Alpha-transforming growth factor in the bovine anterior pituitary gland: secretion by d...
7954416 - Alterations in transforming growth factor-alpha and -beta production and cell responsiv...
8080246 - Increased transforming growth factor-beta, interleukin-4, and interferon-gamma in multi...
17763446 - Pre-b cell colony-enhancing factor/visfatin, a new marker of inflammation in rheumatoid...
17637526 - Growth factors, apoptotic cells and barx1 gene in bone and soft tissue of skeletal clas...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  The Australian and New Zealand journal of surgery     Volume:  66     ISSN:  0004-8682     ISO Abbreviation:  Aust N Z J Surg     Publication Date:  1996 Jul 
Date Detail:
Created Date:  1996-08-12     Completed Date:  1996-08-12     Revised Date:  2009-11-19    
Medline Journal Info:
Nlm Unique ID:  0373115     Medline TA:  Aust N Z J Surg     Country:  AUSTRALIA    
Other Details:
Languages:  eng     Pagination:  464-8     Citation Subset:  IM    
Affiliation:
Department of Pathology, University of Melbourne, St George Hospital, Kogarah, New South Wales, Australia.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Aged, 80 and over
Carcinoma, Squamous Cell / metabolism*
Female
Humans
Immunohistochemistry
Laryngeal Neoplasms / metabolism*
Male
Middle Aged
Polyps / metabolism
Prognosis
Receptor, Epidermal Growth Factor / metabolism*
Regression Analysis
Transforming Growth Factor alpha / metabolism*
Vocal Cords / metabolism
Chemical
Reg. No./Substance:
0/Transforming Growth Factor alpha; EC 2.7.10.1/Receptor, Epidermal Growth Factor

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Modification of growth of desmoid tumours in tissue culture by anti-oestrogenic substances: a prelim...
Next Document:  Bone replacement in head and neck surgery: a biocompatible alternative.